1Ece A, Kelekci S, Hekimoglu A,et al. Neu - trophil activa- tion, protein oxidation, and ceruloplasminlevels in children with Henoch - Schonlein purpura [ J ]. Pediatr Nephrol, 2007,22(8) :1151 - 1157.
2Rech J, Fuchs F, Kallert S, et al. Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch - Schonlein purpura with disseminated organ involvement [ J ]. Clin Rheumatol, 2007,26 ( 1 ) : 112 - 114.
3Deng F, Lu L, Zhang Q, et al. Henoch - schnlein purpura in childhood: treatment and prognosis analysis of 425 cases over a 5 - year period [ J ]. Clin Rheumatol, 2010,29 (4) : 369 - 374.
4Yang YH, Chuang YH, Wang LC, et al. The immunobiolo- gy of Henoch - Schonlein purpura [ J ]. Autoimmun Rev, 2008,7(3 ) : 179 - 184.
5Wu SH, Liao PY, Yin PL, et al. Inverse tempo- ral chan- ges of lipoxin A4 and leukotrienes in children with Henoch - Sch-inlein purpura [ J ]. Prostaglandins Leukot Essent Fatty Acids,2009,80(4) :177 - 183.
8Li YY, Li CR, Wang GB, et al. Investigation of the change in CD4+ T cell subset in children with Henoch - Schonlein purpura[J]. Rheumatol Int,2011, [ Epub ahead of Print].
9Nomura S, Yanabu M, Kido H, et al. Significance of cyto- kines and CD68 - positive microparticles in immune throm- bocytopenic purpura[ J]. Eur J Hoematol, 1995,55 (13) :49 -56.
10Ferrara N. Role of vascular growth factor in the regulation of anglo genesis [ J ]. Kidney Int, 1999,56 ( 3 ) :794 - 814.
6Fervenza FC. Henoch -Sch~nlein purpura nephritis [ J ]. Int J Dermatol, 2003,42(3) :170 - 177.
7Brendel - Muller K, Hahn A, Schneppenheim R, et al. Laboratory signs of activated coagulation are common in Henoch -SchOnlein purpura[ J ]. Pediatr Nephrol,2001,16 ( 12 ) : 1084 - 1088.
8Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch - Sch~,nlein nephritis in children and adults [ J ]. Am J Kidney Dis,2006, 47(6) :993 - 1003.
9Butani L,Morgenstern BZ. Long-term outcome in children after Henoch- SchSnlein purpura nephritis [ J ]. Clin Pediatr ( Phila ) , 2007,46 ( 6 ) : 505 -511.
